Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this document? Why not share!

cv.doc

on

  • 1,163 views

 

Statistics

Views

Total Views
1,163
Views on SlideShare
1,163
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    cv.doc cv.doc Document Transcript

    • CURRICULUM VITAE NAME Jeanne Susan Mandelblatt, MD, MPH BUSINESS ADDRESS Cancer Control Program Lombardi Comprehensive Cancer Ctr, Dept of Oncology Georgetown University School of Medicine 3300 Whitehaven Ave - Suite 4100 Washington, D.C. 20007 Phone (202) 687-0812 / Fax (202) 687-0305 CITIZENSHIP United States LICENSURE DC, NYS BOARD CERTIFICATION 1979 American Board of Family Practice (re-certified 1998; 2005) 1990 Geriatrics, American Boards of Internal Medicine and Family Practice EDUCATION 1968-72 University of Southern California, Los Angeles. California, Bachelor of Arts and Science, Psychology and Biology 1972-76 Columbia University College of Physicians and Surgeons, NYC, MD. 1976-79 Montefiore Medical Center, Bronx, NY, Residency Program in Social Medicine, Department of Family Medicine 1984-87 Mount Sinai School of Medicine, NY, NY, Department of Community Medicine, Preventive Medicine Residency, board eligible 1987-89 Montefiore Medical Center, Bronx, NY, Dept of Medicine, Geriatrics Fellowship 1990-91 Columbia University School of Public Health, Division of Epidemiology, NY, NY, MPH 1994-present Columbia University, Graduate School of Arts and Sciences, School of Public Health, NY, NY, ABD, Cancer Epidemiology 1
    • PROFESSIONAL EXPERIENCE 1981-86 Clinical Instructor, Department of Medicine, Mount Sinai School of Medicine, NY, NY 1986-87 Assistant Clinical Professor, Department of Medicine, Mount Sinai School of Medicine, NY, NY 1987-89 Assistant Professor, Department of Epidemiology and Social Medicine, Albert Einstein School of Medicine. Bronx, NY 1989-93 Assistant Professor and Member, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, NY, NY 1989-93 Assistant Professor and Member, Department of Medicine, Cornell University School of Medicine, NY, NY 1993-94 Associate Professor and Member, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, NY, NY 1993-94 Associate Professor, Department of Medicine, Cornell University Medical School, NY, NY 1994-2001 Associate Professor, Department of Medicine, Georgetown University School of Medicine, Washington, DC 2001-present Professor, Department of Medicine, Georgetown University School of Medicine, Washington, DC 1994-present Director, Cancer and Aging Research, Cancer Control Program, Lombardi Comprehensive Cancer Center, Washington, DC 1996-2001 Director, Cancer Clinical and Economic Outcomes Core, Lombardi Cancer Center, Washington, DC 1999-00 Co-Director, Cancer Control Program, Lombardi Comprehensive Cancer Center, Washington, DC 1999-2000 Acting Director, Division of Behavioral and Health Outcomes Research, Department of Oncology, GUMC, Washington, DC 1999-2001 Associate Professor, Department of Oncology, Georgetown School of Medicine, Washington, DC 2001-present Professor, Department of Oncology, Georgetown School of Medicine, Washington, DC 2000-2008 Director, Cancer Control Program, Lombardi Comprehensive Cancer Center, 2
    • Washington, DC 2000-2008 Director, Division of Health Behaviors and Outcomes, Department of Oncology, GUMC, Washington, DC 2008-present Associate Director for Population Sciences, Lombardi Comprehensive Cancer Center, Washington, DC AWARDS AND HONORS 1976 Magna Cum Laude, University of Southern California 1989 Academic Award, National Institute on Aging 2006 Komen Foundation Professor of Survivorship Award 2002, 2007 Senior Cancer Control Scientist Award, National Cancer Institute PROFESSIONAL SOCIETIES 1979-present American Academy of Family Physicians 1985-1994; 2007-present Society for General Internal Medicine 1986-present American Public Health Association 1989-present American Society of Preventive Oncology 1998-present Cancer and Leukemia Group B 2008-present American Society of Clinical Oncology PUBLIC SERVICE Peer Review Activities 1994-Present National Cancer Institute: Scientific Review Committee member for RFA review 1996 Center for Human Genome Research: Ad hoc Reviewer on study section: Ethical, Legal, and Social Implications of Human Genome Research 1997-98 National Cancer Institute: Member of review committee and site visitor for Program Project applications 1998 National Institutes of Health, Sub-Committee E/F: Ad hoc grant reviewer 1997 National Institutes of Health, Small Business Innovation Research Program: Member of Review Committee 1999 Agency for Health Care Research and Policy: Member, Health Care Technology and Decision Sciences Special Emphasis Panel 1999-2002 National Institutes of Health, Center of Scientific Review: Member, Social Sciences, Nursing, Epidemiology, and Methods Study Section I 2002-present National Institutes of Health, Center of Scientific Review: Member, Sub- 3
    • Committee E. Cancer Control Program Projects. 2007-present National Institutes of Health, Center of Scientific Review: Health Services and Organizational Delivery (HSOD) Study Section National Committees 1992-95 Office of Disease Prevention and Health Promotion, DHSS: Member, Panel on the Cost-Effectiveness in Health and Medicine 1993 Major's Office, New York City Health and Hospitals Corporation: Member, "Blue Ribbon Panel on Women's Health" 1994-1996 Member, Panel on Cost-Effectiveness in Health and Medicine, US DHHS, Office of Disease Prevention and Health Promotion 1997 NIH/National Cancer Institute: Member, Breast Cancer Peer Review Group, Health Outcomes Committee 1997-99 Program for the Evaluation of Medical Technologies, Advisory Board Member, Harvard University 1998-2005 Cancer and Leukemia Group B: Member, Executive Committee Member, Cancer Control and Health Outcomes Committee 1998-present Cancer and Leukemia Group B: Member, Cancer in the Elderly Working Group 1998-2004 United States Preventive Services Task Force: Senior Scientific Advisor 1998 Institute of Medicine, Nat. Cancer Policy Board: “Ensuring Quality Cancer Care" 1999-2005 Cancer and Leukemia Group B: Vice Chair, Clinical Economics and Health Services Subcommittee of the Cancer Control and Health Outcomes Committee 2000 Cancer Outcomes Measurement Working Group. Member, NCI 2003 American Cancer Society. Cervical Cancer Screening. Elderly Working Group 2008 American Society of Clinical Oncology. Program Committee, Health Services Research Editorial Activities 1987-present Manuscript Reviewer: Journal of the American Medical Association, Annals of Internal Medicine, Journal of Clinical Oncology, Journal of General Internal Medicine, Journal of the National Cancer Institute, Cancer Epidemiology Biomarkers and Prevention, Preventive Medicine, American Journal of Preventive Medicine, American Journal of Public Health, Medical Care and 4
    • others 2004-present Editorial Board, Journal of Clinical Oncology 2007-present Editorial Board, Journal of Cancer Survivorship INVITED LECTURES (selected past subset) Presenter, 8th Annual International Symposium on Prevention and Detection of Cancer, International Society for Preventive Oncology, "Is HIV a Co-Factor for Cervical Cancer?" Nice, France, March 17, 1993 Presenter, 8th Annual International Symposium on Prevention and Detection of Cancer, International Society for Preventive Oncology, "Physician-based Interventions to Increase Breast Cancer Screening", Nice, France, March 17, 1993 Keynote Speaker, Cancer and Leukemia Group B Spring Workshop, Cancer Control Committee, "Breast and Cervical Cancer Screening for Minority Elderly Women", Baltimore, Maryland, May 5, 1993 Symposium Co-Leader, American Society of Preventive Oncology, "Use of Cost-Effectiveness and Decision Analysis in Evaluating Cancer Services." Washington, DC, 1994 Panel Speaker, "Historical Perspectives on Cancer Outcomes Research", St. Mary's Annual Symposium on Cancer Quality of Life, Long Beach, California, 1995 Lead Speaker, Kaiser Permanente of Northern California, "Evidence for Cervical Cancer Screening Policies", Oakland, California, October, 1996 Faculty, American Society of Preventive Oncology, New Investigator's Workshop, Washington, DC, March, 1998 Speaker, Agency for Health Care Policy and Research Second Annual Meeting of Study Section Members, "Cost-Effectiveness Analysis: State of the Art, Emerging Issues, and Application", Washington, DC October 7, 1999. Plenary Speaker, Society of Medical Decision Making Annual Meeting, "Cost-Effectiveness of Pap Smear Screening - A Public Policy Success", Cleveland, Ohio, September 2000 Speaker, International Human Papillomavirus Meeting, "Cost-Effectiveness of Different Cervical Cancer Screening Strategies in Under-developed Countries", Barcelona, Spain, July 27, 2000 Plenary Speaker, Cancer and Leukemia Group B, "Breast Cancer Treatment Choices and Outcomes in Older Women: Lessons from the Real World", New Orleans, June 9, 2000 Faculty, American Society of Preventive Oncology, New Investigator's Workshop, Washington, DC, March 5, 2000 5
    • Panel Speaker, "Barriers to Assessing Quality Cancer Care", Ensuring Quality Cancer Care, Robert H. Lurie Cancer Center, Chicago, Illinois, November 10, 2000 Lead Speaker and Workshop Leader, National Institute of Aging and National Cancer Institute, "The Role of Cancer Centers in Leading Gero-Oncology Research - Lessons from Cancer Control", NIA Conference on Aging and Cancer Centers, June 2001 Preparing an RO3 application. NCI, Center for Reducing Cancer Health Disparities, 2007, 2008 Preparing a Career Development Award Application. Society for Medical Decision Making, Oct 21, 2007, Oct 2008 UNIVERSITY SERVICE University Committees 1996-99 Research Review Committee, Division of Prevention and Control Research, Lombardi Cancer Center 1997-00 Cancer Committee, Lombardi Cancer Center, Department of Oncology 1999-2002 Clinical Research Committee, IRB , Department of Oncology 1999 Cross-Campus Committee to Develop a Center on Aging (Maxine Weinstein, chair) 2000-present Executive Committee, Lombardi Comprehensive Cancer Center 2000-01 Member, Search Committee for Cancer Center Director and Chair of the Department of Oncology Community Lectures and Service (selected) 1987-89 Chairperson, Cancer Task Force, New York City Health and Hospital Corporation 1995 Presentation on "Breast Cancer in Older Women" to AARP's Breast Care Campaign, Healing Legacies and the Art of Hollis Sigler 1995 Presentation on "Patterns of Breast Cancer Care" to oncologists and surgeons at Sibley Hospital 1996 Presentation on "Breast Cancer Screening in Older Women" to AARP's Breast Care Campaign 1997 Presentation on "Breast Cancer in the Elderly" at Oncology Grand Rounds, George Washington Medical Center 6
    • 2002-2006 Chair, DC Cancer Coalition/Consortium, Cancer Control Plan 2006-present Executive Committee, DC Cancer Consortium TEACHING ACTIVITIES (selected) 1981-87 Clinical Preceptor, Department of Ambulatory Care, City Hospital Center at Elmhurst 1984-87 Section Leader and Mentor, Community Medicine Research Clerkship, Department of Community Medicine, Mt. Sinai School of Medicine 1984-87 Section Leader, Epidemiology and Biostatistics Core Curriculum, Department of Community Medicine, Mt. Sinai School of Medicine 1987-89 Course Director, Research Design in Geriatric Medicine, Division of Geriatrics, Montefiore Medical Center and Albert Einstein School of Medicine 1987-89 Section Leader, Epidemiology and Biostatistics Core Medical Student Curriculum, Department of Epidemiology and Social Medicine, A. Einstein School of Medicine 1989-94 Course Director, Research Design in Primary Care/Critical Appraisal of the Medical Literature, General Internal Medicine, Cornell Univ. School of Medicine Associate Professor, Georgetown University: 1994-2001 Clinical Preceptor, Division of Primary Care, Department of Medicine, Georgetown University Medical Center 1994-2001 Mentor, Cancer Control Program, Lombardi Cancer Center, Department of Oncology, Georgetown University Medical Center 1996 Lecturer, Institute for Health Care Policy and Research Seminar Series 1997 Lecturer, Tumor Biology I, Department of Cell Biology 1998 Group Co-Leader, Introduction to the Patient, Georgetown University School of Medicine. 1999 Lecturer, Tumor Biology I, Department of Cell Biology 1999-2002 Fellowship Director, Primary Care Research Methods, Department of Medicine, Georgetown University School of Medicine. Professor, Georgetown University: 2001-present Clinical Preceptor, Division of Primary Care, Department of Medicine, 7
    • Georgetown University Medical Center 2001-present Mentor, Cancer Control Program, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center 2001-present Lectures in Tumor Biology Program and Cancer Control Master’s Program Post-Doctoral Trainees (selected) 1996-98 George Sawaya, MD, NCI Mentored Clinical Scientist Development Award, Cervical Cancer Screening in Older Women 1996-99 William Lawrence, MD, MsC, Dept. of Defense Career/IDEA Grant, Translation of BRCA1/2 Testing into Clinical Practice 1997-2005 Ann O'Malley, MD, MPH, Dept. of Defense Career Development Award, Cancer Screening in Multi-ethnic and Under-served Populations 1997-00 Caroline Burnett, PhD, NINR Career Development Award, Breast Cancer Screening in Elderly Black Women 1999-present Wenchi Liang, PhD, NCI Preventive Oncology Career Development Award, Cancer Screening in Chinese Women NCI, RO1, Increasing Colorectal Cancer Screening by Chinese Physicians 2000-2005 Robin Yabroff, PhD, NCI Preventive Oncology Career Development Award, Follow-up of Abnormal Cancer Screening 2001-Present Vanessa Sheppard, PhD, National Institute on Aging/National Cancer Institute, Understanding Black Women’s Chemotherapy Decisions, Minority Investigator Supplement, Older Women’s Chemotherapy Decisions. Komen Foundation, A Navigator Delivered Skills Intervention to Improve Communication and Decision-Making among African American Breast Cancer Patients. Komen National Race For the Cure, A Comprehensive Culturally and Linguistically Peer Approach to Navigating the DC Breast Health System. American Cancer Society Mentored Scholar Research Grant, Closing the Gap: Increasing Adherence to Adjuvant Therapy in Black Women. 2002-2006 Melissa Figueiredo, PhD, Komen and NCI grants, Quality of Life in Latina Breast Cancer Survivors and NCI, Chemotherapy Decisions and Outcomes in Women Age 65 Years or Older with Operable, Newly Diagnosed Breast Cancer 8
    • 2002-Present Judy Wang, PhD, Department of Defense, Breast Cancer Career Development Award, The Influence of Culture on Women’s Breast Cancer Susan G. Komen Breast Cancer Foundation Special Population Research Grant, Reducing Disparities in Breast Cancer Screening in Chinese American women American Cancer Society Mentored Scholar Research Grant, Promoting Adherence to Mammography Use in Chinese American Women National Cancer Institute, R03 research award, Promoting Adherence to Mammography Use in Chinese American Women Lance Armstrong Foundation, Career Award, Chinese Breast Cancer Survivors 2007-present Maria Lopez, PhD, RO3 CNP pilot research award, Smoking Cessation in Latino Males NCI supplement, Developing a scale of Latino Cultural Health Values. 2007-present Barbara Kreling, PhD, RO3 CNP pilot research award, Comparing Hospice use in Latinos and Whites RO3 CNP pilot research award, Barriers to Chemotherapy in Latinos Patients ACS Palliative Care Award, Developing a LHW Intervention to Improve Latino Caregiver Outcomes SCHOLARSHIP AND RESEARCH Peer-Reviewed Grant Support - Previous Assistant and Associate Professor, Cornell and Memorial Sloan Kettering Cancer Center: 1989-90 Principal Investigator, Old, Poor, Black: Combating Cancer Triple Jeopardy, USDHHS NCI Grant # RO3 CA51614, $31,717 1989-92 Co-Investigator, Emergency Room Cancer Screening Program (Freeman PI), USDHHS NCI Grant # RO1 CA50520, $630,533. 1989-94 Principal Investigator, Breast and Cervix Cancer Control in the Elderly, NIA Grant # KO8 AG00471, $350,000. 1990-91 Principal Investigator, "Professional Education to Enhance Early Cancer Detection in Public Hospitals", NYC American Cancer Society, $10,000. 1990-93 Co-Investigator, Cancer Control Needs in Multi-Ethnic Communities (Kerner PI), USDHHS NCI Grant # RO1 CA53083, $257,684 9
    • 1991-92 Co-Investigator, Loss of Primary Care: Health Outcomes Among the Uninsured, United Hospital Fund, Special Projects, NY, $85,000. 1993-94 Principal Investigator, Molecular Epidemiology of Cervical Neoplasia in Older Blacks, New York Community Trust, $100,000. Associate Professor, Georgetown University: 1994-97 Co-Investigator, Cost-Effectiveness of Breast Cancer Treatment in the Elderly (Hadley PI), Dept. of Defense, Grant # DAM17-94-J-4212, $852,136. 1994-97 Co-Investigator, Follow-up of Abnormal Mammograms in African-American Women (Kerner PI), USDHHS, NCI, Grant # 1R01 CA62360-01, $845,308. 1994-98 Co-Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer Treatment in the Elderly (Hadley PI), AHCPR PORT, Grant # R01 CA08395 $4,801,480. 1997-98 Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer: Elderly African-Americans, AHCPR Supplement, Grant # R01 HS08395 $141,337. 1996-Jan 01 Principal Investigator, Cancer Clinical and Economic Outcomes Core, Breast Cancer Center Grant (Lippman PI), Dept of Defense, Grant #DAMD17-96- C-6069, $4.2M. 1996-Jan 01 Co-Investigator, Impact of Genetic Testing for Breast Cancer Susceptibility, Dept of Defense (DAMD17-96-C-6069), $758,594 (PI: Lerman). 1997-June 01 Principal Investigator, The Cost-Effectiveness of HPV Screening for Cervical Cancer in Older Women, National Institute of Aging, Grant # R01 CA74187 $766,392. 1997-02 Co-Investigator, Decisions and Outcomes of BRCA1/2 Testing in Newly Diagnosed Breast Cancer Patients (R01 CA/HG74861), National Cancer Institute, $1,921,385 (PI: Lerman/Schwartz). 1998-June 01 Principal Investigator, (Georgetown Sub-contract; M. Fahs PI), ACost- Effectiveness Analysis of Breast Cancer Control for Older African-Americans, National Cancer Institute, Grant # 1 R01 CA72908, $1,417,007. 1998-01 Co-Investigator, Comparing Models of Counseling for BRCA1/2 Testing (Renewal) (2R01 HG01846), NIH/National Human Genome Research Institute, $1,844,172 (PI: Lerman/Schwartz). 1998-Sept 01 Principal Investigator, Care, Costs, and Outcomes of Local Breast Cancer Treatment in the Elderly, AHCPR PORT, Grant # R01 CA08395, $4,801,480. 10
    • 1998-02 Co-investigator, Breast Cancer: Preparing for Survivorship,National Cancer Institute (PI: Ganz). 1999-02 Principal Investigator, A Phase II Clinical Study of Indole-3-Carbinol vs. Placebo for Efficacy in Human Papillomavirus (HPV) Eradication. National Cancer Institute, Grant # N01 CA95138, $1,092,568. 1999-02 Co-investigator, Cohort Study of Cancer Patient Caregiver Outcomes, National Institute of Nursing Research (Ingham). 1999-03 Principal Investigator, Institutional NRSA (Primary Care Research Methods T32), HRSA, Grant # 6T32 PE10017, $522,276 per year. 2000-June 01 Principal Investigator, (Georgetown Sub-contract; M. Fahs PI),Towards Optimal Screening Strategies: Upper Age Limits for Mammography Screening, Supplement to Cost-Effectiveness Analysis of Breast Cancer Control for Older African-Americans, National Cancer Institute, Grant # 1R01 CA72908, $67,670. 2000-02 Co-Investigator, Breast Cancer Genetic Susceptibility Testing - A Primary Care Perspective. (PI: Lawrence) DoD, Grant # DAMD17-00-1-0268, $148,718. 2000-04 Principal Investigator, Outcomes Across the Spectrum of Breast Cancer Care (CISNET), National Cancer Institute, Grant # 1U01 CA88283A, $755,158. 2000-05 Principal Investigator, (Georgetown Sub-Contract, E. Huerta, PI), Marketing Cancer Control to Latin Americans, National Cancer Institute, Grant # 1U01 CA86114, $2,277,347. 2001-08 Principal Investigator, Chemotherapy Decisions and Outcomes for the Elderly, National Cancer Institute, Grant #U10 CA84131, $2,500,000. Peer-Reviewed Grant Support – Active Professor, Georgetown University: National Cancer Institute (Mandelblatt) 08/16/02 – 06/30/12 2 K05 CA96940 “Cancer Control at the Intersection of Aging Research” This grant provides career development support for cancer and aging and minority research to develop new initiatives and mentoring. National Cancer Institute (Weiner) 05/1/2002-4/30/09 NIH 5P30 51008 Cancer Center Support Grant Associate Director for Population Science 11
    • National Cancer Institute (Mandelblatt) 09/01/05 - 08/31/10 2U01 CA88283A “CISNET: Outcomes Across the Spectrum of Breast Cancer Care” To model trends in cancer incidence and mortality by age, health, and race. National Cancer Institute (Schwartz) 07/01/2004 – 06/30/2009 5 R01 CA074861-08 “Decisions & Outcomes of BRCA ½ Test for Breast Patients” -- This project tests the impact of genetic testing and counseling on treatment decisions and outcomes and tests the cost-effectiveness of different treatment options for women with mutations. National Cancer Institute (Mandelblatt/Huerta) 04/01/05 – 3/31/10 5 U01 CA114593-02 “Latin American Cancer Research Coalition” To approve cancer outcomes and underserved Hispanic populations. Department of Defense (Mandelblatt/Neugut) 03/01/05 – 2/28/10 DDEF CU52144301 “Racial Disparities in the Initiation and Intensity of Adjuvant Therapy in Breast Cancer” To improve cancer outcomes and underserved Black populations. National Cancer Institute (Mandelblatt/ Patierno) 09/29/05- 08/31/2010* NIH 5U01CA116937-02 “DC Patient Navigation Project” To test the effectiveness and cost-effectiveness of patient navigation *transferred to Eng-Wong in Nov 2008 National Cancer Institute (Mandelblatt) 07/01/07 – 06/30/12 5R01CA124924 “Developing an Index of Physiological Age” To develop a predictive index for chemotherapy toxicity in older women National Cancer Institute (Mandelblatt) 2R01CA127617 (continuation of U10 CA84131) 04/01/08-03/31/15 “Who Cares for Elderly Cancer Survivors and Does it Matter for Quality” To describe the types of physicians who care for survivors and test how specialty affects quality of care, satisfaction and quality of life. National Cancer Institute (Co-investigator, PI: Graham) 04/01/08– 3/31/109 R21CA#### “Using the Internet to Reach Latino Smokers for Cessation” 12
    • American Cancer Society (Mandelblatt, Kreling) 03/01/08-02/28/10 ####### “End of Life Care in Latinos” National Cancer Institute 12/01/2008 – 11/30/2013 1R01CA129769 (Mandelblatt) “Older Breast Cancer Patients: Risk for Cognitive Decline National Cancer Institute 1R01CA129142 (PI: Kinney, co-investigator: Mandelblatt) 7/01/2009 – 10/31/2014 “Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women” PEER-REVIEWED PUBLICATIONS Instructor and Assistant Professor, Mt. Sinai School of Medicine: 1. Mandelblatt JS, Hammond DB. Gynecological Care of Elderly Women: Is Papanicolaou Smear Testing Necessary? Mt Sinai J Med 1985;52:284-290. 2. Mandelblatt JS, Skovron ML, Gopaul I. Papanicolaou Smear Screening and the Elderly. JAMA 1985;253:3251. 3. Mandelblatt JS, Gopaul I, Wistreich M. Gynecological Care of Elderly Women in a Primary Care Setting: Another Look at Papanicolaou Smear Testing. JAMA 1986;256:367-371. 4. Mandelblatt JS, Gopaul I, Wistreich M. Papanicolaou Smear Testing in Elderly Women. JAMA 1986;256:2819-2820. 5. Ziffer A, Song P, Mandelblatt JS. Preventive Health Practices in a Teaching Hospital: Housestaff Performance of Gyn Screening. Amer J of Prev Med 1987;3(3):142-146. 6. Mandelblatt JS, Adler RA, Bennett NM, Fein OT, et al. Ambulatory Care Activities and Responses to Cost Containment. J of Gen Med 1987;2:388-393. Assistant Professor, A. Einstein School of Medicine: 7. Mandelblatt JS, Fahs M. Cost Effectiveness of Cervical Cancer Screening for Elderly Low Income Women. JAMA 1988;259:2409-2413. 8. Tarr D, Palacio H, Mandelblatt JS. The Role of Primary Care Physicians in Pap Smear Screening of Elderly Women. NYS J Med 1988;88:296-299. 9. Wheat ME, Mandelblatt JS. Pap Smear Screening in Women 65 and Over. J Amer Geriatrics Soc 1988;36:827-830. 13
    • 10.Mandelblatt J. Cervical cancer screening in primary care: issues and recommendations. Prim Care. 1989 Mar;16(1):133-55. Assistant and Associate Professor, Cornell and Memorial Sloan Kettering Cancer Center: 11.Mandelblatt J, Schechter C, Fahs M, Muller, C. Clinical implications of screening for cervical cancer under Medicare: The natural history of cervical cancer in the elderly: What do we know? What do we need to know? Amer J Obstet and Gynecol 1991;164:644-51. 12.Mandelblatt JS, Andrews H, Kerner JF, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer. AJPH 1991;81:646-649. 13.Mandelblatt JS. Papanicolaou testing after hysterectomy. JAMA 1991; 266: 1289. 14.Mandelblatt J, Fahs M, Garibaldi K, Senie R, Peterson H. The association between human immunodeficiency virus infection and cervical neoplasia. AIDS 1992;6:173-178. 15.Mandelblatt JS, Wheat ME, Monane M, Moshief R, Hollenberg J, Tang J. Breast cancer screening for elderly women with and without co-morbid conditions: a decision model. Annals of Internal Medicine 1992;116:722-730. 16.Mandelblatt JS, Richard R, Thomas L, Chauhan P, Traxler M, Lakin P, et al. Is HPV associated with cervical neoplasia in the elderly? Gynecologic Oncology 1992;46:6-12. 17.Fahs M, Mandelblatt J, Schechter C, Muller C. The costs and effectiveness of cervical cancer screening in the elderly. Annals of Internal Medicine 1992;117:520-527. 18.Kanetsky P, Mandelblatt J, Richard R, Gammon M. Risk factors for cervical cancer in black, elderly women. Ethnicity and Disease 1992;2:337-342. 19.Mandelblatt JS, Traxler M, Lakin P, Kanetsky P, Kao R. Mammography and Papanicolaou smear use by elderly poor black women. JAGS 1992;40:1001-1007. 20.Mandelblatt J, Traxler M, Lakin P, Thomas L, Chauhan P, Matseoane S, Kanetsky P. A nurse practitioner intervention to increase breast and cervical cancer screening for elderly, poor, black women. J of Gen Intern Med 1993;8:173-178. 21. Mandelblatt J. Squamous cell cancer of the cervix, immune senescence and HPV: is cervical cancer an age-related neoplasm? Adv Exp Med Biol. 1993;330:13-26. Review. 22.Mandelblatt J, Traxler M, Lakin P, Kanetsky P, Kao R. Targeting breast and cervical cancer screening to elderly poor black women: Who will participate? Prev Med 1993;22:20-33. 23.Kerner JF, Dusenbury L, Mandelblatt JS. Poverty and Cultural Diversity: Challenges for Health Promotion among the Medically Under served. Ann Rev of PH 1993;14:355-377. 14
    • 24.Andrews H, Kerner JF, Zauber A, Mandelblatt J, Pittman J, Struening E. Using census and mortality data to target small areas for breast, cervix and colorectal cancer screening. AJPH 1993; 84:56-61. 25.Mandelblatt J, Traxler M, Thomas L, Chauhan P, Kanetsky P, Lakin P, Matseoane S, Breast and cervical cancer screening of poor, elderly, black women. Amer J Prev Med 1993;9:133-138. 26.Kurman RJ, Henson DE, Herbst AL, et al and the NCI Workshop (Mandelblatt JS, participant). Guidelines for Management of Abnormal Cervical Cytology. JAMA 1994;271:1866-1869. Associate Professor, Georgetown University: 27.Mandelblatt JS, Kanetsky PA. Effectiveness of interventions to enhance physician screening for breast cancer. J of Family Practice 1995;40:162-171. 28.Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Impact of Access and Social Context on Breast Stage at Diagnosis. J of Health Care for the Poor and Underserved 1995;6(3):342-351. 29.Rojas M, Mandelblatt J, Cagney K, Kerner JF, Freeman H. Barriers to Follow-Up of Abnormal Mammograms among Low Income Minority Women. Ethnicity and Health 1996;1(3):221-228. 30.Fahs MC, Plichta SB, Mandelblatt JS. Cost-Effective Policies for Cervical Cancer Screening. PharmacoEconomics 1996;9(3):211-230. 31.Mandelblatt JS, Eisenberg JM. Historical and Methodological Perspectives on Cancer Outcomes Research. Oncology 1996;9:23-32. 32.Russell L, for members of the Panel on Cost-Effectiveness in Health and Medicine (Mandelblatt, panel member). The Role of Cost-Effectiveness Analysis for Decision Making in Health. JAMA 1996;276:1172-1177. 33.Weinstein M, for members of the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for Conducting Cost-Effectiveness Analysis (Mandelblatt, panel member). JAMA 1996;276:1253-1258. 34.Seigel J, for members of the Panel on Cost-Effectiveness in Health and Medicine (Mandelblatt, panel member). Reporting the Results of Cost-Effectiveness Analysis. JAMA 1996;276:1339-1341. 35.Mandelblatt JS, Phillips R. Cervical Cancer - How Often and Why - to Screen Older Women. Geriatrics 1996;51:45-48. 36.Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Late Stage Diagnosis of 15
    • Colorectal Cancer: The Relationships Between Poverty, Race, Gender, Age, and Settings of Care. AJPH 1996;86:1794-1797. 37.Mandelblatt, J, Freeman H, Williams S, Trowers R, Cagney K, Winczewski D, Kerner J. The Implementation of breast and cervical cancer screening in a public hospital emergency room. Annals of Emergency Med 1996;28:493-498. 38.Mandelblatt JS, Freeman H, Winczewski D, Cagney K, Kerner JF. The costs and yields of emergency room screening for breast and cervix cancer. Amer J Public Health 1997;87:1182-1189. 39.O’Malley A, Mandelblatt J, Kerner J, Gold K, et al. Primary Care in Breast and Cervix Cancer Screening Among Multi-Ethnic Populations. Arch Int Med 1997;157:1462-1470. 40.Mandelblatt J, Fryback D, Weinstein M, Gold M, Russell L, Hadorn D, and members of the Panel on Cost-Effectiveness in Health and Medicine. Assessing the Effectiveness of Health Interventions. J Gen Intern Med 1997;12:551-558. 41.Taylor KL, Kerner JF, Gold KF, Mandelblatt JS. Ever vs Never Smoking Among an Urban, Multiethnic Sample of Haitian-, Caribbean-, and US-born Blacks. Preventive Medicine 1997;26:855-865. 42.Kanetsky PA, Gammon M, Mandelblatt JS et al. Cigarette Smoking and Cervical Dysplasia Among non-Hispanic Black Women. Cancer Detection and Prevention 1998;22(2):109-119. 43.Lawrence W, Liang, W, Mandelblatt, J, et al. Serendipitous MRI Lesions. JNCI 1998;90(23):1792-800. 44.Kanetsky PA, Gammon M, Mandelblatt JS et al. Dietary Intake and Blood Levels of Lycopene: Association with Cervical Dysplasia Among non-Hispanic Black Women., Nutrition and Cancer, 1998 31(1):31-40. 45.O’Malley AS, Kerner JF, Johnson A, Mandelblatt JS. Acculturation and Breast Cancer Screening Among Hispanic Women in New York City. American Journal of Public Health, 1999;89(2):219-227. 46.Mandelblatt J, O’Malley A, Gold K, Kerner J. Breast and Cervix Cancer Screening Use Among Multi-Ethnic Women: Role of Age, Health, and Source of Care. Prev Med 1999;28:418-425. 47.Mandelblatt JS, Kanetsky PA, Eggert, L, Gold K. Is HIV Infection a Co-factor for Cervical Squamous Cell Neoplasia? Cancer Epidemiology, Biomarkers, and Prevention 1999;8:97-106. 48.Mandelblatt J, Ganz P, Kahn K. A Proposed Agenda for the Measurement of Breast Cancer Quality of Care in Oncology Practice. J Clin Oncol 1999;17(8):2614-2622. 16
    • 49.Mandelblatt J and Yabroff RK. Effectiveness of Interventions Designed to Increase Mammography Use: A Meta-Analysis of Provider-targeted Strategies. CA Epi Biomarkers Prev 1999;8:759-767. 50.Yabroff RK and Mandelblatt J. Interventions Targeted toward Patients to Increase Mammography Use. CA Epi Biomarkers Prev 1999;8:749-757. 51.Mandelblatt JS, Yabroff KR, Kerner JF. Equitable Access to Cancer Services: A Review of Barriers to Quality Care. Cancer 1999;86:2378-90. 52.Mandelblatt JS, Yabroff KR. Breast and Cervical Cancer Screening in the Elderly: Recommendations and Challenges for the 21st Century. JAMWA, 2000; 55:210-5. 53.Mandelblatt J, Yabroff KR, Lawrence W, Yi B, Orosz G, Bloom HG, Schecther CB, et al. Screening Mammography in the Elderly. Research on Breast Cancer in Older Women Consortium. JAMA, 2000; 283, 3202-3. 54.Mandelblatt J, Hadley J, Kerner J, Schulman K, et al. Patterns of Breast Carcinoma Treatment in Older Women: Patient Preference, Clinical, and Physician Influences. Cancer, 2000; 89:561-73. 55.Yabroff R, Mandelblatt J, Kerner J. Effectiveness of Interventions to Improve Follow-up After Abnormal Cervical Cancer Screening. Prev Med, 2000: 31(4) 429-439. 56.Padgett D, Yedidia M, Kerner J, Mandelblatt J. The Emotional Consequences of False Positive Mammography: African-American Women’s Reactions in Their Own Words. Women’s Health, 2000: 33(3-4) 1-14. 57.Sawaya GF, Grady, D, Kerlikowske K, La Valleur J, Barnabei VM, Bass K, Snyder TE, Pickar JH, Agarwal S, Mandelblatt J. The Positive Predictive Value of Cervical Smears in Previously Screened Post-menopausal Women: The Heart and Estrogen/progesterone Replacement Study (HERS). Annals of Internal Medicine 2000;133:942-950. 58.Lawrence W, Mandelblatt J, Liang W, Peshkin B, Lerman C. The Costs of Genetic Counseling and Testing for BRCA1/2 Mutations. Ca Epi Biomarkers Prev, 2001: 10(5) 475-481. 59.Mandelblatt JS, Bierman AS, Gold K, Zhang Y, Ng J, Maserejan N, Meropol N, Hadley J, Silliman R. Constructs of Burden of Illness in Older Breast Cancer Patients: A Comparison of Measurement Methods. Health Svc Res 2001:36(6 pt 1) 1085-1107. 60.Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, Gold K, Hwang YT, Hadley J. Measuring and Predicting Surgeons: Practice Styles for Breast Cancer Treatment in Older Women. Medical Care 2001: 39(3) 228-242. 61.Hadley J, Mandelblatt J, Mitchell J, et al. Medicare Fees and Small Area Variations in Breast Conserving Surgery Among Elderly Women. Medical Care Research and Review, 17
    • 2001:58(3) 334-360. 62.Saha S, Hoerger TJ, Pignone M, Teutsch SM, Helfand M, Mandelblatt JS. The Art and Science of Incorporating Cost-Effectiveness into Evidence-based Recommendations for Clinical Preventive Services. Amer J Prev Med, 2001:20(3 Suppl):36-43. 63.Sawaya G, Grady, D, Kerlikowske K, Hiatt R, Mandelblatt J. Advancing Age and Cervical Cancer Screening and Prognosis. JAGS, 2001:49(11) 1499-504. 64.Hagen MD, Garber A, Goldie SJ, Lafata J, Mandelblatt J, Melter D, Neumann P, Sox H, Tsevat J. Does Cost-Effectiveness Analysis Make a Difference? Lessons from Pap Smears. Med Decis Making, 2001;21(4):307-23. 65. Kerner JF, Mandelblatt JS, Silliman RA, Lynch JJ, Senie R, Cohen C, Hwang YT; OPTIONS Research Team. Outcomes and preferences for treatment in older women nationwide study. Screening mammography and breast cancer treatment patterns in older women. Breast Cancer Res Treat. 2001 Sep;69(1):81-91 66.Yabroff K, O'Malley A, Mangan P, Mandelblatt J. Inreach and Outreach Interventions to Improve Mammagraphy Use. JAMWA 2001:56(4):166-174. 67.O’Malley AS, Lawrence W, Liang W, Lynn J, Kerner J, Mandelblatt J. Feasibility of Mobile Cancer Screening and Prevention. J Health Care Poor Underserved, 2002;13(3):298-319. 68.Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM Jr, Hwang YT, Mandelblatt JS. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer. 2002 15;94(10):2534-41. 69.Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, et al. Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer. 2002 Dec 15;95(12):2445-54. 70.Mandelblatt, J., Lawrence, W., Gaffiken, L., and et al. Cost and benefits of alternative cervical cancer screening programs in less developed countries. Journal of the National Cancer Institute. 2002: 94(19): 1469-1483. 71.Mandelbaltt JS, Lawrence WF, Womack SM, Jacobson D, Hwang YT, Gold, K, Barter J, Shah K. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287(18): 2372-81, 2002. 72.Mandelblatt JS, Kerner JF, Hadley J, Hwang YT, Eggert L, Johnson LE, et al. Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer. 2002 Oct 1;95(7):1401-14. 73.Klassen AC, Smith AL, Meissner HI, Zabora J, Curbow B, Mandeblatt J. If we gave away mammograms, who would get them? A neighborhood evaluation of a no-cost breast cancer 18
    • screening program. Prev Med.2002;34(1):13-21. 74.Liang W, Burnett CB, Rowland JH, Meropol NJ, Eggert L, Hwang YT, Silliman RA, Weeks JC, Mandelblatt JS. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol. 2002;20(4):1008-16. 75.O'Malley AS, Renteria-Weitzman R, Huerta EE, Mandelblatt J. Patient and provider priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos. Ethn Dis. 2002 Summer;12(3):383-91. 76.Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Jul 16;137(2):96-104. Review. Summary for patients in: Ann Intern Med. 2002 Jul 16;137(2):I38. 77.O'Malley, A. S., Forrest, C. B., and Mandelblatt, J. Adherence of low-income women to cancer screening recommendations. J.Gen.Intern.Med., 17: 144-154, 2002. 78. Saslow D, Runowicz CD*, Solomon D, Moscicki B, Smith RA, Eyre HJ, Cohen C. * Mandelblatt J, member of Work Group on Interval, Older Women, and Hysterectomy. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin, Nov 2002; 52: 342 - 362. 79.Hadley, J., Mandelblatt, J., Mitchell, J., Weeks, J. C., Guadagnoli, E, and Wang, Q. Medicare Breast Surgery Fees and Treatment Received by Older Women with Localized Breast Cancer. Health Serv Res. 2003 Apr;38(2):553-73. 80.O'Malley AS, Mandelblatt J. Delivery of preventive services for low-income persons over age 50: a comparison of community health clinics to private doctors' offices.J Community Health. 2003 Jun;28(3):185-97. 81.Polsky D, Mandelblatt JS, Weeks JC, Venditti L, Hwang YT, Glick HA. Economic evaluation of breast cancer treatment: considering the value of patient choice. J Clin Oncol. 2003 Mar 15;21(6):1139-46. 82.Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, et al. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J Clin Oncol. 2003 Mar 1;21(5):855-63. 83.Hadley J, Polsky D, Mandelblatt JS, Mitchell JM, Weeks JC, Wang Q, et al. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population. Health Econ. 2003 Mar;12(3):171-86. 84.Mandelblatt J, Figueiredo M, Cullen J. Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? Health and Quality of Life Outcomes 2003, 1:45 (17 Sep 2003). 19
    • 85.O'Malley AS, Gonzalez R, Sheppard V, Huerta E, Mandelblatt J. Primary care cancer control interventions that include Latinos. Am J Prev Med,. 2003 Oct;25(3):264-71. 86.Yabroff KR, Mangan T, Mandelblatt J. Effectiveness of interventions to increase Papanicolaou smear use. J Am Board Fam Pract. 2003 May-Jun;16(3):188-203. 87.Kerner J; Yedidia M; Padgett D, Muth B; Washington K; Tefft M, Mandelblatt J, et al. Realizing the promise of breast cancer screening: Clinical follow-up after abnormal screening among Black Women. Prev Med. 2003 Aug;37(2):92-101. 88.Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost Work Group of the U.S. Preventive Services Task Force. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Nov 18;139(10):835-42. 89.Cantor SB, Fahs MC, Mandelblatt JS, Myers E, Sanders G. Decision science and cervical cancer. Cancer. 2003 Nov 1; 98(9 Suppl): 2003-8. 90. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003 Sep; 60(3): 294-331. 91. Liang W, WF, Burnett CB, Hwang YT, Freedman M, Trock BJ, Mandelblatt JS, Lippman ME. Acceptability of diagnostic tests for breast cancer. Breast Cancer Res Treat. 2003 May; 79(2): 199-206. 92. Smith RA, Saslow D, Sawyer KA, Burke W(for the High-Risk Work Group), Costanza ME (for The Screening Older Women Work Group*), Evans P (for The Mammography Work Group), Foster RS (for The Physical Examination Work Group), Hendrick E (for the New Technologies Work Group), Eyre HJ, Sener S (for The Breast Cancer Advisory Group). *Mandelblatt J, member of The Screening Older Women Work Group. American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 2003; 53:141-161. 93. Mandelblatt J. Diagnostic Hurdle. AHRQ WebM&M. February 2004. Available at: http:// webmm.ahrq.gov/cases.aspx?ic=48. Accessed March 10, 2004. 94. Mandelblatt J., Schechter C.B., Yabroff, R.K., Lawrence W., Dignam J., Muennig P., Chavez Y., Cullen J., Fahs M. Benefits and Costs of Interventions to Improve Breast Cancer Outcomes In African-American Women. Journal of Clinical Oncology, 2004; 22: 2554-2566. 95.Mandelblatt J, Armetta C, Yabroff KR, Liang W, Lawrence W. Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Natl Cancer Inst Monogr. 2004; (33):8-44. 20
    • 96. Mandelblatt J, Lawrence W, Yi B, King J. The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening. Arch Intern Med. 2004 Feb 9;164(3):245-7. 97.Cullen J., Schwartz M.D., Lawrence W.F., Selby J.V., Mandelblatt J.S. Short-term impact of cancer prevention and screening activities on quality-of-life. Journal of Clinical Oncology, 2004; 22: 943-952. 98.Figueiredo, M.I., Cullen, J., Hwang Y-T, Rowland J.H., Mandelblatt J.S. Breast cancer treatment in older women: Does getting what you want improve your long-term body image and mental health? Journal of Clinical Oncology, 2004; 22 (19): 4002-4009. 99.Liang W, Yuan EH, Mandelblatt JS, Pasick RJ. How Chinese women view health and cancer screening? Results from focus groups and implications for intervention. Ethnicity and Health, 2004, 9(3):283-04. 100.O’Malley AS, Beaton E, Yabroff R, Abramson R, Mandelblatt J. Patient and Provider Barriers to Colorectal Cancer Screening in Safety-Net Primary Care. Prev Med. 2004;39:56-63. 101.O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of preventive services among low-income African-American women. Prev Med. 2004 Jun;38(6):777-85. 102.Yabroff KR, Mandelblatt JS, Ingham J. The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med. 2004 Apr;18(3):202-16. 103.Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005 Oct 27;353(17):1784-92. 104.Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J, Heinze R, Cohen HJ, Muss HB. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol. 2005 Apr 1;23(10):2201-7. 105.Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M, Fox S, Orosz G, Silliman R, Cullen J, Balducci L; Breast Cancer in Older Women Research Consortium. Toward optimal screening strategies for older women. J Gen Intern Med. 2005 Jun;20(6):487-96. 106.Pignone M, Saha S, Hoerger T, Lohr KN, Teutsch S, Mandelblatt J. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1073-9. 21
    • 107.Sheppard VB, Cox LS, Kanamori MJ, Canar J, Rodriguez Y, Goodman M, Pomeroy J, Mandelblatt J, Huerta EE and LACRC. If you build it, they will come: methods for recruiting Latinos into cancer research. J Gen Intern Med. 2005 May;20(5):444-7. 108.Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, Kerner JF, Mandelblatt JS. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005 Spring; 21(2):149-57 109.Mandelblatt J, Kaufman E, Sheppard VB, et al. Breast cancer prevention in community clinics: will Latina patients participate in clinical trials? Prev Med. 2005; 40(6):611-8. 110.O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165:2129-35. 111.Tallarico M, Figueiredo M, Goodman M, Kreling B, Mandelblatt J. Psychosocial determinants and outcomes of chemotherapy in older women with breast cancer: what do we know? What do we need to know? Cancer J. 2005 Nov-Dec;11(6):518-28. 112.Wang JH, Liang W, Chen MY, Cullen J, Feng S, Yi B, Schwartz MD, Mandelblatt JS. Influence of culture and cancer worry on colorectal cancer screening in older Chinese American women. Ethnicity and Disease, 2006:16(2): 404-411. 113.Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ; ALTS Group. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006 Jan 18;98(2):92-100. 114.Mandelblatt JS, Lawrence WF, Cullen J, Stanton AL, Krupnick JL, Kwan L, Ganz PA. Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol. 2006 Jan 1;24(1):77-84. 115.Kreling B, Figueiredo M, Sheppard V, Mandelblatt J. A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention. Psychooncology. 2006 Apr 6. 2006 Dec;15(12):1065-76. 116.Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr. 2006; (36):47-55. 117.Hillner BE, Mandelblatt J. Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst. 2006 May 17;98(10):660-1. 118.Liang W, Kasman D, Wang JH, Yuan EH, Mandelblatt JS. Communication between older women and physicians: Preliminary implications for satisfaction and intention to have mammography. Patient Educ Couns. 2006 Dec;64(1-3):387-92. Epub 2006 Jul 26. 22
    • 119.Kreling B, Canar J, Catipon E, Mandelblatt J, et al. Latin American Cancer Research Coalition: A Community Primary Care-Academic Partnership Model for Cancer Control. Cancer. 2006 Oct 15;107(8 Suppl):2015-22. 120.Mandelblatt J. Treating breast cancer: the age old dilemma of old age. J Clin Oncol. 2006 Sep 20;24(27):4369-70. 121.Mandelblatt J, Kreling B, Figeuriedo M, Feng S. What is the impact of shared decision making on treatment and outcomes for older women with breast cancer? J Clin Oncol. 2006 Oct 20;24(30):4908-13. 122.Mandelblatt J. To screen or not to screen older women for breast cancer: A new twist on an old question or will we ever invest in getting the answers? J Clin Oncol. 2007 Jul 20;25(21):2991-2. 123.Wang JH, Liang W, Schwartz, M. D., Lee MM, Kreling, B., and Mandelblatt JS. Evaluation of the impact of a culturally-tailored educational video on changes in breast cancer-related behavior in Chinese women. Health Educ Behav 2007, 2007 Jun 29; [Epub ahead of print]. 124.Sheppard VB, Figueiredo M, Canar J, Goodman M, Caicedo L, Kaufman A, Norling G, Mandelblatt J. Latina a Latina(SM): developing a breast cancer decision support intervention. Psychooncology. 2008 Apr;17(4):383-91. 125.Mandelblatt JS, Cullen J, Lawrence WF, Stanton AL, Yi B, Kwan L, Ganz PA. Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. J Clin Oncol. 2008 Apr 1;26(10):1684-90. 126.Liang W, Chen MY, Ma GX, Mandelblatt JS. Knowledge, perceptions, and communication about colorectal cancer screening among Chinese American primary care physicians. Clinical Medicine: Gastroenterology, 2008; 1:21-26. 127.Liang W, Wang J H, Chen MY, Feng S, Yi B, Lee MM, Schwartz MD, Pasick RJ, Mandelblatt JS. Developing and validating a measure of Chinese cultural views of health and cancer. Health Education and Behavior 2008 Jun;35(3):361-75. 128.Wang JH, Sheppard VB, Schwartz MD, Liang W, Mandelblatt JS. Disparities in cervical cancer screening between Asian and White women. Cancer Epidemiology Biomakers & Prevention. 2008 Aug;17(8):1968-73. 129.Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Greene A, Calhoun E, Mandelblatt JS, Paskett ED, Raich PC; Patient Navigation Research Program. Patient navigation: state of the art or is it science? Cancer. 2008 Oct 15;113(8):1999-2010. 130.Mandelblatt JS, Silliman R. Hanging in the Balance: Making Decisions About the Benefits and Harms of Breast Cancer Screening Among the Oldest Old Without a Safety Net 23
    • of Scientific Evidence. J Clin Oncol. 2009 27: 487-490. 131.Sheppard VB, Wang J, Yi B, Harrison TM, Feng S, Huerta EE, Mandelblatt JS; Latin American Cancer Research Coalition. Are health-care relationships important for mammography adherence in Latinas?J Gen Intern Med. 2008 Dec;23(12):2024-30. 132.Graves KD, Huerta E, Cullen J, Kaufman E, Sheppard V, Luta G, Isaacs C, Schwartz MD, Mandelblatt J. Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence. Cancer Causes Control. 2008 Dec;19(10):1373-82. 133.Mandelblatt JS, Potosky AL. On the road to improving the quality of breast cancer care: a distance still to travel. Med Care. 2008 Aug;46(8):759-61 134.Sheppard VB, Williams KP, Harrison TM, Jennings Y, Lucas W, Stephen J, Robinson D, Mandelblatt JS, Taylor KL. Development of decision-support intervention for Black women with breast cancer. Psychooncology. 2009 Mar 6. 135.Liang W, Wang J, Chen MY, Feng S, Yi B, Mandelblatt JS. Cultural Views, Language Ability, and Mammography Use in Chinese American Women. Health Educ Behav. 2009 Feb 20. [Epub ahead of print] 136.Liang W, Wang JH, Chen MY, Mandelblatt JS. Language use and the receipt of cancer screening recommendations by immigrant Chinese American women. J Womens Health. 2009 Feb;18(2):201-7. 137.Ramsey S, Whitley E, Mears VM, McKoy JM, Everhart RM, Caswell RJ, Fiscella K, Hurd TC, Battalgia T, Mandelblatt J, For the PNRP. Evaluating the Cost Effectiveness of Cancer Patient Navigation: Conceptual and Practical Issues. Cancer. 2009, in press. 138.Mandelblatt JS, Cronin K, Bailey S, et al. CISNET Breast Working Group. Effects of mammography screening under different screening schedules: model estimates of poteitnal benefits and harms. Annals Int Med 2009, in press. BOOK CHAPTERS (selected) Mandelblatt J. Cervical Cancer Screening. In: Primary Care Clinics of North America. Cancer Prevention. Ed: R Burack. WB Saunders, Phil, Pa. March 1989 (pp 133-155). Fahs M, Mandelblatt J. Cost-Effectiveness of Cervical Cancer Screening Among Elderly Low Income Women. In: Preventing Disease. Beyond the Rhetoric. Eds: Richard Goldbloom and Robert Lawrence, Springer Verlag, NY, 1990 (pp 441-446). Muller CM, Mandelblatt J, Schechter C. The Costs and Effectiveness of Screening for Cervical Cancer in Elderly Women. A Paper in the OTA's Series on Preventive Services Under Medicare. Health Program, Office of Technology Assessment, U.S. Congress, Washington, DC, Feb 1990. 24
    • Mandelblatt, JS. Immune Senescence, HPV and Cervical Cancer In: Yang S, Warner H, eds. Underlying Molecular, Cellular, and Immunological Factors in Age-Related Neoplasms. Plenum Press, New York, 1993 (pp 13-26). Mandelblatt JS. Breast and Cervical Cancer Screening in Elderly Poor Women. In: Oncology: Principles and Practice. Cancer Prevention Update. Eds: DeVita, Hellman, and Rosenberg. JB Lippincott, Phil, Pa, 1994, pages 1-7. Mandelblatt J, Fryback D, Weinstein M, Gold M, Russell L, Hadorn D, and members of the Panel on Cost-Effectiveness in Health and Medicine. Assessing the Effectiveness of Health Interventions. In: Cost-Effectiveness in Health and Medicine. Editors: Gold M, Seigel J, Russell L, and Weinstein M. Oxford University Press, New York, 1996 (pp 135-175). Russell L, Seigel J, Daniels N, Luce B, Mandelblatt J, and members of the Panel on Cost- Effectiveness in Health and Medicine. Cost-Effectiveness Analysis for Decision Making in Health: Roles and Limitations. Editors: Gold M, Seigel J, Russell L, and Weinstein M. Oxford University Press, New York, 1996 (pp 3-24). Kerner JF, Trock B, Mandelblatt JS. Breast Cancer in Minority Women. In: Harris and Lippman M, ed. Breast Diseases, 2nd Edition; 1999, pgs 955-66. Mandelblatt J, Selby J. Outcomes for Preventive Care. In: Cancer Outcomes Measurement Working Group. Gotay and Lipscomb, editors. Oxford Univ Press, 2003. Kerner JF, Trock B, Mandelblatt JS. Breast Cancer in Minority Women. In: Harris and Lippman M, ed. Breast Diseases, 3rd Edition. 2004. Mandelblatt JS, Liang W, Sheppard V, Wang J, Isaacs C. Breast Cancer in Minority Women. In: Harris and Lippman M, ed. Breast Diseases, 4th Edition. 2008. ABSTRACTS Available upon request 25